Brain Cancer Vaccine's Immune Response Key to Outcomes (HealthDay)

[riky]

Brain Cancer Vaccine's Immune Response Key  to Outcomes
    (HealthDay)

 


HealthDay - TUESDAY, July 15 (HealthDay News) -- An in-trial dendritic cell
vaccine that fights malignant brain tumors called glioblastoma multiforme
(GBM) may help boost a patient's immunity response and improve the
outcome, a new report says.


You are not allowed to view links. Register or Login/news.yahoo.com/s/hsn/20080715/hl_hsn/braincancervaccinesimmuneresponsekeytooutcomes